Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hirata

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|August 23, 2022
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)Yasuhiro Shimojima, Dai Kishida, Takanori Ichikawa, et al.
Modern Rheumatology|October 10, 2025
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVASSatoshi Omura, Takashi Kida, Junya Kitai, et al.
Rheumatology International|November 12, 2025
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)Genki Kidoguchi, Yusuke Yoshida, Satoshi Omura, et al.
Clinical Rheumatology|August 12, 2024
Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVASGenki Kidoguchi, Yusuke Yoshida, Hirofumi Watanabe, et al.
International Journal of Rheumatic Diseases|February 11, 2026
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVASSatoshi Omura, Takashi Kida, Hironori Inoue, et al.
Modern Rheumatology|October 6, 2023
Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVASHideaki Sofue, Takashi Kida, Aiko Hirano, et al.
Rheumatology (Oxford, England)|April 12, 2024
Effectiveness of intravenous methylprednisolone pulse in patients with severe microscopic polyangiitis and granulomatosis with polyangiitisSatoshi Omura, Takashi Kida, Hisashi Noma, et al.
The Journal of Rheumatology|June 1, 2023
Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS)Yusuke Yoshida, Naoki Nakamoto, Naoya Oka, et al.
Respiratory Investigation|May 5, 2026
The guide for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease 2025Yasuhiro Kondoh, Masashi Bando, Yutaka Kawahito, et al.
Rheumatology (Oxford, England)|October 10, 2025
Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitisSatoshi Akao, Masaru Shimizu, Kazushi Maruo, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|August 23, 2022
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)Yasuhiro Shimojima, Dai Kishida, Takanori Ichikawa, et al.
Modern Rheumatology|October 10, 2025
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVASSatoshi Omura, Takashi Kida, Junya Kitai, et al.
Rheumatology International|November 12, 2025
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)Genki Kidoguchi, Yusuke Yoshida, Satoshi Omura, et al.
Clinical Rheumatology|August 12, 2024
Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVASGenki Kidoguchi, Yusuke Yoshida, Hirofumi Watanabe, et al.
International Journal of Rheumatic Diseases|February 11, 2026
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVASSatoshi Omura, Takashi Kida, Hironori Inoue, et al.
Modern Rheumatology|October 6, 2023
Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVASHideaki Sofue, Takashi Kida, Aiko Hirano, et al.
Rheumatology (Oxford, England)|April 12, 2024
Effectiveness of intravenous methylprednisolone pulse in patients with severe microscopic polyangiitis and granulomatosis with polyangiitisSatoshi Omura, Takashi Kida, Hisashi Noma, et al.
The Journal of Rheumatology|June 1, 2023
Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS)Yusuke Yoshida, Naoki Nakamoto, Naoya Oka, et al.
Respiratory Investigation|May 5, 2026
The guide for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease 2025Yasuhiro Kondoh, Masashi Bando, Yutaka Kawahito, et al.
Rheumatology (Oxford, England)|October 10, 2025
Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitisSatoshi Akao, Masaru Shimizu, Kazushi Maruo, et al.
Pageof 16